{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T11:28:57Z","timestamp":1769858937772,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s10067-018-04407-y","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T00:50:55Z","timestamp":1546908655000},"page":"1243-1249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Concomitant association of giant cell arteritis and malignancy: a multicenter retrospective case-control study"],"prefix":"10.1007","volume":"38","author":[{"name":"on behalf of the French Study Group for Large Vessel Vasculitis (GEFA)","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Deshayes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Liozon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Chanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Sacr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Moulinet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Blanchard-Delaunay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Espitia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Groh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Versini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Le Gallou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-E.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Grobost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Samson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Mourot Cottet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Mazodier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dartevel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Campagne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bienvenu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Daumas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Aouba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"de Boysson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"key":"4407_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1056\/NEJMcp1214825","volume":"371","author":"CM Weyand","year":"2014","unstructured":"Weyand CM, Goronzy JJ (2014) Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med 371:50\u201357","journal-title":"N Engl J Med"},{"key":"4407_CR2","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1001\/jama.2016.5444","volume":"315","author":"F Buttgereit","year":"2016","unstructured":"Buttgereit F, Dejaco C, Matteson EL, Dasgupta B (2016) Polymyalgia rheumatica and giant cell arteritis: a systematic review. JAMA 315:2442","journal-title":"JAMA"},{"key":"4407_CR3","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.autrev.2017.05.014","volume":"16","author":"M Samson","year":"2017","unstructured":"Samson M, Corbera-Bellalta M, Audia S, Planas-Rigol E, Martin L, Cid MC, Bonnotte B (2017) Recent advances in our understanding of giant cell arteritis pathogenesis. Autoimmun Rev 16:833\u2013844","journal-title":"Autoimmun Rev"},{"key":"4407_CR4","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3324\/haematol.2011.056283","volume":"97","author":"SM Ramadan","year":"2012","unstructured":"Ramadan SM, Fouad TM, Summa V, Hasan SK, Lo-Coco F (2012) Acute myeloid leukemia developing in patients with autoimmune diseases. Haematologica 97:805\u2013817","journal-title":"Haematologica"},{"key":"4407_CR5","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3324\/haematol.2009.020412","volume":"95","author":"SY Kristinsson","year":"2010","unstructured":"Kristinsson SY, Landgren O, Samuelsson J, Bjorkholm M, Goldin LR (2010) Autoimmunity and the risk of myeloproliferative neoplasms. Haematologica 95:1216\u20131220","journal-title":"Haematologica"},{"key":"4407_CR6","doi-asserted-by":"crossref","unstructured":"Fain O, Hamidou M, Cacoub P, Godeau B, Wechsler B, ParI\u00e8s J, Stirnemann J, Morin AS, Gatfosse M, Hanslik T, Belmatoug N, Bl\u00e9try O, Cevallos R, Delevaux I, Fisher E, Hayem G, Kaplan G, le Hello C, Mouthon L, Larroche C, Lemaire V, Piette AM, Piette JC, Ponge T, Puechal X, Rossert J, Sarrot-Reynauld F, Sicard D, Ziza JM, Kahn MF, Guillevin L (2007) Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum 57:1473\u20131480","DOI":"10.1002\/art.23085"},{"key":"4407_CR7","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s11926-012-0281-3","volume":"14","author":"A Agha","year":"2012","unstructured":"Agha A, Bateman H, Sterrett A, Valeriano-Marcet J (2012) Myelodysplasia and malignancy-associated vasculitis. Curr Rheumatol Rep 14:526\u2013531","journal-title":"Curr Rheumatol Rep"},{"key":"4407_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/1529-0131(200012)13:6<417::AID-ART13>3.0.CO;2-T","volume":"13","author":"TE Hutson","year":"2000","unstructured":"Hutson TE, Hoffman GS (2000) Temporal concurrence of vasculitis and cancer: a report of 12 cases. Arthritis Care Res 13:417\u2013423","journal-title":"Arthritis Care Res"},{"key":"4407_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0738-081X(93)90115-S","volume":"11","author":"R Kurzrock","year":"1993","unstructured":"Kurzrock R, Cohen PR (1993) Vasculitis and cancer. Clin Dermatol 11:175\u2013187","journal-title":"Clin Dermatol"},{"key":"4407_CR10","first-page":"294","volume":"35","author":"R Solans-Laque","year":"2008","unstructured":"Solans-Laque R, Bosch-Gil JA, P\u00e9rez-Bocanegra C et al (2008) Paraneoplastic vasculitis in patients with solid tumors: report of 15 cases. J Rheumatol 35:294\u2013304","journal-title":"J Rheumatol"},{"key":"4407_CR11","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s11739-017-1626-8","volume":"12","author":"M Bellan","year":"2017","unstructured":"Bellan M, Boggio E, Sola D, Gibbin A, Gualerzi A, Favretto S, Guaschino G, Bonometti R, Pedrazzoli R, Pirisi M, Sainaghi PP (2017) Association between rheumatic diseases and cancer: results from a clinical practice cohort study. Intern Emerg Med 12:621\u2013627","journal-title":"Intern Emerg Med"},{"key":"4407_CR12","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.revmed.2016.12.010","volume":"38","author":"J Galland","year":"2017","unstructured":"Galland J, Kawski H, Guichard J-F, Maurier F (2017) Vascularite des gros vaisseaux et syndrome my\u00e9lodysplasique : une association rare. Rev Med Interne 38:474\u2013477","journal-title":"Rev Med Interne"},{"key":"4407_CR13","doi-asserted-by":"publisher","first-page":"e3540","DOI":"10.1097\/MD.0000000000003540","volume":"95","author":"K-H Yu","year":"2016","unstructured":"Yu K-H, Kuo C-F, Huang LH, Huang WK, See LC (2016) Cancer risk in patients with inflammatory systemic autoimmune rheumatic diseases: a nationwide population-based dynamic cohort study in Taiwan. Medicine (Baltimore) 95:e3540","journal-title":"Medicine (Baltimore)"},{"key":"4407_CR14","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.jaad.2005.10.011","volume":"55","author":"JM Zurada","year":"2006","unstructured":"Zurada JM, Ward KM, Grossman ME (2006) Henoch-Sch\u00f6nlein purpura associated with malignancy in adults. J Am Acad Dermatol 55:S65\u2013S70","journal-title":"J Am Acad Dermatol"},{"key":"4407_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/rheumatology\/39.4.417","volume":"39","author":"MA Hamidou","year":"2000","unstructured":"Hamidou MA, Derenne S, Audrain MA, Berthelot JM, Boumalassa A, Grolleau JY (2000) Prevalence of rheumatic manifestations and antineutrophil cytoplasmic antibodies in haematological malignancies. A prospective study. Rheumatology (Oxford) 39:417\u2013420","journal-title":"Rheumatology (Oxford)"},{"key":"4407_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-2141.1995.tb05310.x","volume":"91","author":"H Enright","year":"1995","unstructured":"Enright H, Jacob HS, Vercellotti G, Howe R, Belzer M, Miller W (1995) Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haematol 91:403\u2013408","journal-title":"Br J Haematol"},{"key":"4407_CR17","doi-asserted-by":"crossref","unstructured":"Giannouli S, Voulgarelis M, Zintzaras E, Tzioufas AG, Moutsopoulos HM (2004) Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study. Rheumatology 43:626\u2013632","DOI":"10.1093\/rheumatology\/keh136"},{"key":"4407_CR18","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1002\/acr.20504","volume":"63","author":"A Hollanda de","year":"2011","unstructured":"de Hollanda A, Beucher A, Henrion D, Ghali A, Lavigne C, L\u00e9vesque H, Hamidou M, Subra JF, Ifrah N, Belizna C (2011) Systemic and immune manifestations in myelodysplasia: a multicenter retrospective study. Arthritis Care Res (Hoboken) 63:1188\u20131194","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4407_CR19","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0248-8663(01)00367-8","volume":"22","author":"S Berthier","year":"2001","unstructured":"Berthier S, Magy N, Gil H, Becker Schneider M, Vuitton DA, Dupond JL (2001) My\u00e9lodysplasies et maladies syst\u00e9miques. Une association non fortuite. Rev Med Interne 22:428\u2013432","journal-title":"Rev Med Interne"},{"key":"4407_CR20","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1080\/10428194.2017.1379075","volume":"59","author":"V Jachiet","year":"2018","unstructured":"Jachiet V, Mekinian A, Carrat F, Grignano E, Retbi A, Boffa JJ, Ronco P, Rondeau E, Sellam J, Berenbaum F, Chazouill\u00e8res O, Capron J, Alamowitch S, Chasset F, Frances C, Coppo P, Fain O, on behalf of French Network of systemic and immune disorders associated with hemopathies and cancer (MINHEMON) (2018) Autoimmune manifestations associated with lymphoma: characteristics and outcome in a multicenter retrospective cohort study. Leuk Lymphoma 59:1399\u20131405","journal-title":"Leuk Lymphoma"},{"key":"4407_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1600-0609.1995.tb00231.x","volume":"55","author":"R Billstr\u00f6m","year":"1995","unstructured":"Billstr\u00f6m R, Johansson H, Johansson B, Mitelman F (1995) Immune-mediated complications in patients with myelodysplastic syndromes\u2013clinical and cytogenetic features. Eur J Haematol 55:42\u201348","journal-title":"Eur J Haematol"},{"key":"4407_CR22","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.leukres.2013.04.007","volume":"37","author":"OA Ustwani","year":"2013","unstructured":"Ustwani OA, Ford LA, Sait SJN, Block AMW, Barcos M, Vigil CE, Griffiths EA, Thompson JE, Wang ES, Ambrus J Jr, Wetzler M (2013) Myelodysplastic syndromes and autoimmune diseases\u2014case series and review of literature. Leuk Res 37:894\u2013899","journal-title":"Leuk Res"},{"key":"4407_CR23","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/S0755-4982(04)98914-2","volume":"33","author":"E Liozon","year":"2004","unstructured":"Liozon E, Loustaud-Ratti V, Soria P, Bezanahary H, Fauchais AL, Nadalon S, Rhaiem K, Ly K, Vidal \u00c9 (2004) Disease associations in 250 patients with temporal (giant cell) arteritis. Presse Med 33:1304\u20131312","journal-title":"Presse Med"},{"key":"4407_CR24","first-page":"1606","volume":"33","author":"E Liozon","year":"2006","unstructured":"Liozon E, Loustaud V, Fauchais A-L, Soria P, Ly K, Ouattara B, Rhaiem K, Nadalon S, Vidal E (2006) Concurrent temporal (giant cell) arteritis and malignancy: report of 20 patients with review of the literature. J Rheumatol 33:1606\u20131614","journal-title":"J Rheumatol"},{"key":"4407_CR25","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/BF02207931","volume":"14","author":"JCC Mertens","year":"1995","unstructured":"Mertens JCC, Willemsen G, Van Saase J et al (1995) Polymyalgia rheumatica and temporal arteritis: a retrospective study of 111 patients. Clin Rheumatol 14:650\u2013655","journal-title":"Clin Rheumatol"},{"key":"4407_CR26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.semarthrit.2007.03.006","volume":"37","author":"MA Gonzalez-Gay","year":"2007","unstructured":"Gonzalez-Gay MA, Lopez-Diaz MJ, Martinez-Lado L, Pe\u00f1a-Sagredo JL, Lopez-Agreda H, Miranda-Filloy JA, Gonzalez-Juanatey C, Sanchez-Andrade A, Martin J, Llorca J (2007) Cancer in biopsy-proven giant cell arteritis. A population-based study. Semin Arthritis Rheum 37:156\u2013163","journal-title":"Semin Arthritis Rheum"},{"key":"4407_CR27","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/rheumatology\/kep409","volume":"49","author":"CL Hill","year":"2010","unstructured":"Hill CL, Cole A, Rischmueller M, Dodd T, Coleman M, Tucker G, Roberts-Thomson P (2010) Risk of cancer in patients with biopsy-proven giant cell arteritis. Rheumatology 49:756\u2013759","journal-title":"Rheumatology"},{"key":"4407_CR28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/art.27320","volume":"62","author":"TA Kermani","year":"2010","unstructured":"Kermani TA, Sch\u00e4fer VS, Crowson CS et al (2010) Malignancy risk in patients with giant cell arteritis: a population-based cohort study. Arthritis Care Res (Hoboken) 62:149\u2013154","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4407_CR29","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.3899\/jrheum.101254","volume":"38","author":"J Ninan","year":"2011","unstructured":"Ninan J, Nguyen A-M, Cole A et al (2011) Mortality in patients with biopsy-proven giant cell arteritis: a south Australian population-based study. J Rheumatol 38:2215\u20132217","journal-title":"J Rheumatol"},{"key":"4407_CR30","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1007\/s00393-018-0440-7","volume":"77","author":"YH Lee","year":"2018","unstructured":"Lee YH, Song GG (2018) Overall and cause-specific mortality in giant cell arteritis: a meta-analysis. Z Rheumatol 77:946\u2013951. \n                    https:\/\/doi.org\/10.1007\/s00393-018-0440-7","journal-title":"Z Rheumatol"},{"key":"4407_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.0954-6820.1981.tb11604.x","volume":"209","author":"B Bengtsson","year":"1981","unstructured":"Bengtsson B, Malmvall B-E (1981) Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study on ninety patients treated with corticosteroids. Acta Med Scand 209:337\u2013345","journal-title":"Acta Med Scand"},{"key":"4407_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/03009747409097138","volume":"3","author":"J Knorring von","year":"1974","unstructured":"von Knorring J, Somer T (1974) Malignancy in association with polymyalgia rheumatica and temporal arteritis. Scand J Rheumatol 3:129\u2013135","journal-title":"Scand J Rheumatol"},{"key":"4407_CR33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.0954-6820.1986.tb02796.x","volume":"220","author":"R Andersson","year":"1986","unstructured":"Andersson R, Malmvall B-E, Bengtsson B (1986) Long-term corticosteroid treatment in giant cell arteritis. Acta Med Scand 220:465\u2013469","journal-title":"Acta Med Scand"},{"key":"4407_CR34","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1093\/rheumatology\/keq040","volume":"49","author":"J Ji","year":"2010","unstructured":"Ji J, Liu X, Sundquist K, Sundquist J, Hemminki K (2010) Cancer risk in patients hospitalized with polymyalgia rheumatica and giant cell arteritis: a follow-up study in Sweden. Rheumatology 49:1158\u20131163","journal-title":"Rheumatology"},{"key":"4407_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/RHU.0000000000000697","volume":"24","author":"R Je\u0161e","year":"2018","unstructured":"Je\u0161e R, Rotar \u017d, Tom\u0161i\u010d M, Ho\u010devar A (2018) Giant cell arteritis and malignancy-more than just a coincidence? J Clin Rheumatol 24:85\u201386. \n                    https:\/\/doi.org\/10.1097\/RHU.0000000000000697","journal-title":"J Clin Rheumatol"},{"key":"4407_CR36","first-page":"2143","volume":"29","author":"G Myklebust","year":"2002","unstructured":"Myklebust G, Wilsgaard T, Jacobsen BK, Gran JT (2002) No increased frequency of malignant neoplasms in polymyalgia rheumatica and temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls. J Rheumatol 29:2143\u20132147","journal-title":"J Rheumatol"},{"key":"4407_CR37","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.semarthrit.2014.06.004","volume":"44","author":"P Ungprasert","year":"2014","unstructured":"Ungprasert P, Sanguankeo A, Upala S, Knight EL (2014) Risk of malignancy in patients with giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis. Semin Arthritis Rheum 44:366\u2013370","journal-title":"Semin Arthritis Rheum"},{"key":"4407_CR38","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.1780330810","volume":"33","author":"GG Hunder","year":"1990","unstructured":"Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122\u20131128","journal-title":"Arthritis Rheum"},{"key":"4407_CR39","unstructured":"Institut national du cancer (2018) Les cancers en France, \u00e9dition 2017"},{"key":"4407_CR40","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.rdc.2011.09.002","volume":"37","author":"HJ Park","year":"2011","unstructured":"Park HJ, Ranganathan P (2011) Neoplastic and paraneoplastic vasculitis, vasculopathy, and hypercoagulability. Rheum Dis Clin N Am 37:593\u2013606","journal-title":"Rheum Dis Clin N Am"},{"key":"4407_CR41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/rheumatology\/keu303","volume":"54","author":"B Baslund","year":"2015","unstructured":"Baslund B, Helleberg M, Faurschou M, Obel N (2015) Mortality in patients with giant cell arteritis. Rheumatology (Oxford) 54:139\u2013143","journal-title":"Rheumatology (Oxford)"},{"key":"4407_CR42","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1093\/rheumatology\/key028","volume":"57","author":"A Aouba","year":"2018","unstructured":"Aouba A, Gonzalez Chiappe S, Eb M, Delmas C, de Boysson H, Bienvenu B, Rey G, Mahr A (2018) Mortality causes and trends associated with giant cell arteritis: analysis of the French national death certificate database (1980-2011). Rheumatology (Oxford) 57:1047\u20131055","journal-title":"Rheumatology (Oxford)"},{"key":"4407_CR43","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/ard.60.3.293","volume":"60","author":"MA Hamidou","year":"2001","unstructured":"Hamidou MA, El Kouri D, Audrain M, Grolleau JY (2001) Systemic antineutrophil cytoplasmic antibody vasculitis associated with lymphoid neoplasia. Ann Rheum Dis 60:293\u2013295","journal-title":"Ann Rheum Dis"},{"key":"4407_CR44","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/j.jaad.2010.09.732","volume":"66","author":"JO Podjasek","year":"2012","unstructured":"Podjasek JO, Wetter DA, Pittelkow MR, Wada DA (2012) Cutaneous small-vessel vasculitis associated with solid organ malignancies: the Mayo Clinic experience, 1996 to 2009. J Am Acad Dermatol 66:e55\u2013e65","journal-title":"J Am Acad Dermatol"},{"key":"4407_CR45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000446062","volume":"136","author":"O Wolach","year":"2016","unstructured":"Wolach O, Stone R (2016) Autoimmunity and inflammation in myelodysplastic syndromes. Acta Haematol 136:108\u2013117","journal-title":"Acta Haematol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-04407-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-04407-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-04407-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:19:14Z","timestamp":1578356354000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-04407-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["4407"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-04407-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,7]]},"assertion":[{"value":"14 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was conducted in compliance with good clinical practices and the Declaration of Helsinki principles. At the time of this study, in accordance with French public health law (Art. L 1121-1-1, Art. L 1121-1-2), formal approval from an ethics committee was not required for this type of observational study. Our local ethics committee confirmed the observational non-interventional retrospective nature of our cohort.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Maxime Samson declares invitations to congresses by Abbvie, Roche Chuga\u00ef, Actelion, Novartis and LFB; symposium for Roche Chuga\u00ef and belongs to scientific committee of Roche Chuga\u00ef. The other authors declare that they have no relevant financial interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}